These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35320905)

  • 1. Autism and associated disorders: cannabis as a potential therapy.
    Babayeva M; Assefa H; Basu P; Loewy Z
    Front Biosci (Elite Ed); 2022 Jan; 14(1):1. PubMed ID: 35320905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder.
    Poleg S; Kourieh E; Ruban A; Shapira G; Shomron N; Barak B; Offen D
    Transl Psychiatry; 2021 Oct; 11(1):524. PubMed ID: 34645786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid treatment for the symptoms of autism spectrum disorder.
    Aran A; Cayam Rand D
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    Pedrazzi JFC; Ferreira FR; Silva-Amaral D; Lima DA; Hallak JEC; Zuardi AW; Del-Bel EA; Guimarães FS; Costa KCM; Campos AC; Crippa ACS; Crippa JAS
    Psychopharmacology (Berl); 2022 Sep; 239(9):2713-2734. PubMed ID: 35904579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
    Fyke W; Alarcon JM; Velinov M; Chadman KK
    Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.
    Holdman R; Vigil D; Robinson K; Shah P; Contreras AE
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):451-463. PubMed ID: 34432543
    [No Abstract]   [Full Text] [Related]  

  • 8. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.
    Bar-Lev Schleider L; Mechoulam R; Saban N; Meiri G; Novack V
    Sci Rep; 2019 Jan; 9(1):200. PubMed ID: 30655581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of CBD in Autism Spectrum Disorder.
    Pedrazzi JFC; Hassib L; Ferreira FR; Hallak JC; Del-Bel E; Crippa JA
    Int Rev Neurobiol; 2024; 177():149-203. PubMed ID: 39029984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study.
    Hacohen M; Stolar OE; Berkovitch M; Elkana O; Kohn E; Hazan A; Heyman E; Sobol Y; Waissengreen D; Gal E; Dinstein I
    Transl Psychiatry; 2022 Sep; 12(1):375. PubMed ID: 36085294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dopamine Hypothesis of Autism Spectrum Disorder.
    Pavăl D
    Dev Neurosci; 2017; 39(5):355-360. PubMed ID: 28750400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CBD-Enriched
    Fleury-Teixeira P; Caixeta FV; Ramires da Silva LC; Brasil-Neto JP; Malcher-Lopes R
    Front Neurol; 2019; 10():1145. PubMed ID: 31736860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid treatment for autism: a proof-of-concept randomized trial.
    Aran A; Harel M; Cassuto H; Polyansky L; Schnapp A; Wattad N; Shmueli D; Golan D; Castellanos FX
    Mol Autism; 2021 Feb; 12(1):6. PubMed ID: 33536055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats.
    Zamberletti E; Gabaglio M; Woolley-Roberts M; Bingham S; Rubino T; Parolaro D
    Front Cell Neurosci; 2019; 13():367. PubMed ID: 31447649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.
    Siani-Rose M; McKee R; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
    Cannabis Cannabinoid Res; 2023 Aug; 8(4):642-656. PubMed ID: 35343818
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocannabinoid Signaling in Autism.
    Chakrabarti B; Persico A; Battista N; Maccarrone M
    Neurotherapeutics; 2015 Oct; 12(4):837-47. PubMed ID: 26216231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.